Chemoinformaics analysis of HEXADECA-TRANS-2-CIS-9-DIENE-12,14-DIYNOIC-ACID-ISOBUTYLAMIDE
Molecular Weight | 250.382 | nRot | 11 |
Heavy Atom Molecular Weight | 224.174 | nRig | 4 |
Exact Molecular Weight | 250.193 | nRing | 0 |
Solubility: LogS | -4.116 | nHRing | 0 |
Solubility: LogP | 5.7 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 45.6606 |
nHD | 1 | BPOL | 26.9514 |
QED | 0.322 |
Synth | 2.483 |
Natural Product Likeliness | 1.526 |
NR-PPAR-gamma | 0.021 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.005 |
Pgp-sub | 0.032 |
HIA | 0.007 |
CACO-2 | -4.78 |
MDCK | 0.0000265 |
BBB | 0.749 |
PPB | 0.978078 |
VDSS | 0.483 |
FU | 0.0181612 |
CYP1A2-inh | 0.146 |
CYP1A2-sub | 0.546 |
CYP2c19-inh | 0.044 |
CYP2c19-sub | 0.513 |
CYP2c9-inh | 0.235 |
CYP2c9-sub | 0.875 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.258 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0.089 |
CL | 0.962 |
T12 | 0.519 |
hERG | 0.178 |
Ames | 0.559 |
ROA | 0.8 |
SkinSen | 0.986 |
Carcinogencity | 0.341 |
EI | 0.976 |
Respiratory | 0.942 |
NR-Aromatase | 0.382 |
Antiviral | Yes |
Prediction | 0.786284 |